Table 1

Availability of clinical genomic sequencing tests globally: whole-exome sequencing, non-invasive prenatal testing and tumour sequencing

TestNorth AmericaCentral/ South AmericaEuropeMiddle eastAsia/OceaniaOther countries
Whole-exome sequencingUSA
Canada
Mexico
Brazil
Argentina
Colombia
Argentina
Peru
UK, Germany Belgium, Denmark, Netherlands, Sweden, Italy, Spain, Ireland, Estonia, Finland, FranceSaudi Arabia
Qatar
Turkey
Israel
Australia
China
Japan
South Korea
Taiwan
South Africa
Non-invasive prenatal testingUSA
Canada
Mexico
Brazil
Argentina
Colombia
Argentina
Peru
UK, France, Belgium, Denmark, Netherlands, Switzerland, Czech Republic, Sweden, Germany, Italy, Spain IrelandSaudi Arabia
Qatar
Turkey
Israel
Australia
China
Japan
South Korea
Taiwan
South Africa
Tumour sequencingUSA
Canada
Mexico
Brazil
Argentina
Chile
Colombia
Venezuela
Peru
UK, Belgium, Czech Republic, Netherlands, Sweden, Norway, France, Germany, Spain, Italy, Estonia, Finland, IrelandSaudi Arabia
Qatar
Turkey
Israel
Australia
China
Japan
South Korea
Taiwan
South Africa
Egypt
  • Availability is based on the best available information obtained using a range of sources, including the grey literature and interviews with experts (personal communications, Veronique Forest, Marius Van Den Berg, 10/20/20).30 However, this table is illustrative and thus may not include all relevant countries. Also, we could not assess the availability of whole genome (vs exome) independently but many countries have both tests available.